The CD40L-CD40 dyad is another effective immune-checkpoint target for atherosclerosis, which controls a variety of immunological activities, including T cell activation, immunoglobulin isotype switching, macrophage, DC and B-cell activation and proliferation (Kusters et al., 2018). The gene discussed is CD40; the disease is atherosclerosis.